Showing results (1-10 of 209) with videos related to
Sort By:
Pageof 21
Trends in Cancer|June 13, 2017
Malignant Mesothelioma: Time to Translate?Andrea Napolitano, Michele CarboneExpert Review of Respiratory Medicine|August 27, 2015
Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesAngela Bononi, Andrea Napolitano, Harvey I Pass, et al.Oncotarget|July 23, 2016
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesotheliomaMichele Carbone, David Shimizu, Andrea Napolitano, et al.Carcinogenesis|November 9, 2014
Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survivalFrancine Baumann, Erin Flores, Andrea Napolitano, et al.Cancer Research|October 17, 2019
Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic PerspectivesMichele Carbone, Gerry MelinoAnnals of Translational Medicine|July 15, 2017
Mesothelioma: recent highlightsMichele Carbone, Haining YangClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesotheliomaMichele Carbone, Haining YangOncogene|August 24, 2004
Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformationMaurizio Bocchetta, Michele CarboneCancer Biology & Therapy|November 15, 2002
The role of environmental carcinogens, viruses and genetic predisposition in the pathogenesis of mesotheliomaAmy Powers, Michele CarboneMolecular Carcinogenesis|May 2, 2006
Cross reactivity between many anti-human antibodies for their hamster homologs provide the tools to study the signal transduction pathway activated by asbestos and SV40 in the malignant mesothelioma modelBarbara Kroczynska, Michele CarbonePageof 21